Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 long-term administration study of K-115 in glaucoma and ocular hypertension
jRCT2080221525Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ripasudil in open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXG), pigmentary glaucoma (PG) and 1 more, sponsored by Kowa Company, Ltd.
02
Drugs
ripasudil
03
Conditions
open-angle glaucoma (OAG)pseudoexfoliation glaucoma (PXG)pigmentary glaucoma (PG)ocular hypertension
Beyond the preview
Go deeper on jRCT2080221525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221525.